Group 1 - Kaichun Co., Ltd. adjusted the share repurchase price limit from 26.625 yuan/share to 40 yuan/share, effective from June 10, 2025 [1] - Yipin Pharmaceutical's subsidiary received a drug registration certificate for Dexmedetomidine Hydrochloride Injection, a Class 3 chemical drug used for sedation during anesthesia [1] - Bohui Innovation obtained a medical device registration certificate for HPV Genotyping Test Kit, used for qualitative detection of HPV DNA [1][2] Group 2 - Lingyi Zhi Zao's application for issuing convertible bonds and cash payment to acquire 66.46% of Jiangsu Kedasiteng Automotive Technology Co., Ltd. has been accepted by the Shenzhen Stock Exchange [3] - Kemin Food reported a 23.06% year-on-year increase in pig sales in May, with a total of 48,300 pigs sold [4][5] - Meian Sen decided to terminate the issuance of shares to specific objects due to market conditions and strategic considerations [6][7] Group 3 - Zhengbang Technology reported a 146.6% year-on-year increase in pig sales revenue in May, totaling 731 million yuan [9] - Yuanda Holdings plans to reduce the registered capital of its subsidiary from 73 million to 24.3 million USD to optimize asset structure [10] - East China Pharmaceutical's subsidiary received FDA approval for clinical trials of HDM1010 tablets for type 2 diabetes [12] Group 4 - Liangxin Co., Ltd. received a government subsidy of 14.1 million yuan, accounting for 4.52% of its audited net profit for 2024 [13] - Erkang Pharmaceutical's Vitamin B6 Injection passed the consistency evaluation for generic drugs [14] - New Industry received a patent certificate for an antibody related to anti-PIC detection, enhancing detection efficiency [16][15] Group 5 - Dongxing Medical signed a 6 million yuan technology development contract with Shanghai Jiao Tong University for collagen preparation processes [16] - Suchang Chai A's subsidiary will absorb and merge another subsidiary, adjusting internal equity structure [17] - Yibin Technology received a project designation notice from a domestic new energy vehicle company, with an estimated total sales of 256 million yuan over five years [18] Group 6 - Mingchen Health received a cash dividend of 20 million yuan from its subsidiary [19] - Hendi Pharmaceutical obtained a drug registration certificate for Ibuprofen Suspension, a common medication for children [19] - Huaren Pharmaceutical's subsidiary received a drug registration certificate for Dexmedetomidine Hydrochloride Injection, classified as a Category B drug under national medical insurance [20] Group 7 - Enwei Pharmaceutical obtained a renewed drug production license for six key products [21] - Xiaoming Co., Ltd. reported a 45.59% year-on-year increase in chicken product sales in May, totaling 23.25 million birds [23][24] - Shan Natural Gas successfully issued a 350 million yuan short-term financing bond with a 1.78% interest rate [25] Group 8 - Xidamen announced plans for board members to reduce their holdings by up to 581,000 shares [26] - Shentong Technology's shareholder plans to reduce holdings by up to 3% of the company's shares [27] - Saintno Bio plans to distribute a cash dividend of 0.14 yuan per share and a capital increase of 0.4 shares per share [28] Group 9 - *ST King Kong's subsidiary received a debt transfer notice from its controlling shareholder, totaling 364 million yuan [29] - Foxit Software's executives plan to reduce their holdings by a total of 55,800 shares [30] - Youyou Green Energy plans to apply for a bank credit line of up to 1.5 billion yuan [31] Group 10 - Guoxing Optoelectronics plans to distribute a cash dividend of 0.5 yuan per 10 shares [32] - Guangxun Technology plans to distribute a cash dividend of 2.6 yuan per 10 shares [33] - Hanrui Cobalt plans to distribute a cash dividend of 1.5 yuan per 10 shares [35] Group 11 - Tigermed plans to distribute a cash dividend of 3 yuan per 10 shares [37] - Shenliang Holdings plans to distribute a cash dividend of 1.5 yuan per 10 shares [38] - Yishitong plans to distribute a cash dividend of 1 yuan per 10 shares [39]

智通财经6月9日电，领益智造(002600.SZ)公告称，公司拟通过发行可转换公司债券及支付现金的方 式，购买江苏科达斯特恩汽车科技股份有限公司66.46%股权并募集配套资金。近日，公司收到深交所 出具的《关于受理广东领益智造股份有限公司发行可转换为股票的公司债券购买资产并募集配套资金申 请文件的通知》，深交所对公司报送的申请文件进行了核对，认为申请文件齐备，决定予以受理。 领益智造：发行可转换公司债券及支付现金购买资产事项获得深交所受理 ...

| 证券代码：002600 | 证券简称：领益智造 | 公告编号：2025-065 | | --- | --- | --- | | 债券代码：127107 | 债券简称：领益转债 | | 广东领益智造股份有限公司 关于为公司及子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 二、担保进展情况 近日，公司、公司全资子公司成都领益科技有限公司（以下简称"成都领益"）、 东莞领杰金属精密制造科技有限公司（以下简称"东莞领杰"）、深圳市领略数控 设备有限公司（以下简称"领略数控"）、领胜电子科技（深圳）有限公司（以下 简称"领胜电子"）、领益科技（深圳）有限公司（以下简称"领益科技"）、赛尔 康技术（深圳）有限公司（以下简称"赛尔康技术"）分别和招商银行股份有限公 司深圳分行（以下简称"招商银行"）签订了《票据池业务最高额质押合同》，公 司及以上六个全资子公司在招商银行提供的总额为人民币 50,000 万元（含等值 1 / 4 其他币种）的票据池业务授信额度内提供互相质押担保，质押期间为《票据池业 务最高额质押合同》生效之日起至《票据池业务授信 ...

广东领益智造股份有限公司（以下简称"公司"）拟通过发行可转换公司债 券及支付现金的方式，购买常州优融汽车科技有限公司、上海迈环企业管理合伙 企业（有限合伙）、浙江万里扬企业管理有限公司、芜湖华安战新股权投资基金 合伙企业（有限合伙）、常州青枫云港投资中心（有限合伙）、常州星远创业投资 合伙企业（有限合伙）、常州市超领创业投资合伙企业（有限合伙）和江苏信保 投保联动创业投资合伙企业（有限合伙）合计持有的江苏科达斯特恩汽车科技股 份有限公司 66.46%股权并募集配套资金（以下简称"本次交易"）。 公司近日收到深圳证券交易所（以下简称"深交所"）出具的《关于受理广 东领益智造股份有限公司发行可转换为股票的公司债券购买资产并募集配套资 金申请文件的通知》（深证上审〔2025〕75 号）。深交所根据相关规定对公司报送 的发行可转换为股票的公司债券购买资产并募集配套资金申请文件进行了核对， 认为申请文件齐备，决定予以受理。 | 证券代码：002600 | 证券简称：领益智造 公告编号：2025-064 | | --- | --- | | 债券代码：127107 | 债券简称：领益转债 | 广东领益智造股份有限公司 关于 ...

领益智造（002600）公告，公司拟通过发行可转换公司债券及支付现金的方式，购买江苏科达斯特恩汽 车股份有限公司66.46%股权并募集配套资金。公司近日收到深圳证券交易所出具的《关于受理广东领 益智造股份有限公司发行可转换为股票的公司债券购买资产并募集配套资金申请文件的通知》。深交所 认为申请文件齐备，决定予以受理。本次交易尚需通过深交所审核并取得中国证券监督管理委员会同意 注册的批复，最终能否通过审核、取得注册，以及最终通过审核、取得注册的时间仍存在不确定性。 ...

Core Viewpoint - Lingyi Technology (领益智造) has shown a positive stock performance with a 4.47% increase in share price, reflecting strong market interest and ongoing share repurchase activities [1][2]. Company Announcements - As of May 31, 2025, Lingyi Technology has repurchased a total of 26,400,000 shares, with a total transaction amount of approximately 219.66 million yuan [1][2]. - The company announced a share repurchase plan on April 11, 2025, with a budget between 200 million yuan and 400 million yuan, and a maximum repurchase price of 13.18 yuan per share [1]. - The company has established a dedicated securities account for the repurchase and has disclosed relevant announcements on April 15 and April 19, 2025 [1]. Profit Distribution - The company approved a profit distribution plan on March 27, 2025, proposing a cash dividend of 0.2 yuan per 10 shares, with the ex-dividend date set for May 7, 2025 [2]. - The maximum repurchase price was adjusted to 13.16 yuan per share, with an estimated repurchase quantity of approximately 30,395,136 shares, representing 0.43% of the total share capital [2]. - As of May 31, 2025, the repurchased shares accounted for 0.38% of the total share capital, with the highest and lowest transaction prices recorded at 8.55 yuan and 8.08 yuan per share, respectively [2].

Market Performance - The wireless charging concept sector declined by 0.39%, ranking among the top losers in the concept sectors as of the market close on June 3 [1] - Notable declines within the sector included Wangzi New Materials, which hit the daily limit down, and other companies like Wan'an Technology and Huayang Group also saw significant drops [1] Sector Highlights - The top performing concept sectors included: - China-Korea Free Trade Zone: +4.23% - Cell Immunotherapy: +3.87% - Recombinant Protein: +3.64% - Football Concept: +3.56% [1] Capital Flow - The wireless charging concept sector experienced a net outflow of 788 million yuan, with 40 stocks seeing net outflows and 8 stocks exceeding 30 million yuan in outflows [1] - Wangzi New Materials led the outflow with a net outflow of 266 million yuan, followed by Sairisi and Haier Smart Home with outflows of 92.22 million yuan and 79.01 million yuan respectively [1] Stock Performance - Among the stocks in the wireless charging concept, the following had notable performances: - Wangzi New Materials: -10.02% with a turnover rate of 42.39% - Sairisi: -1.04% with a turnover rate of 1.19% - Haier Smart Home: -1.24% with a turnover rate of 0.68% [2] - Conversely, stocks with net inflows included: - Xianying Technology: +3.16% with a net inflow of 17.95 million yuan - Hengdian East Magnetic: -0.70% with a net inflow of 13.65 million yuan - Shanghai Beiling: +0.64% with a net inflow of 13.34 million yuan [3]

截至6月3日收盘，同花顺果指数概念下跌0.41%，位居概念板块跌幅榜前列，板块内，闻泰科技、珠海 冠宇、鹏鼎控股等跌幅居前，股价上涨的有5只，涨幅居前的有东山精密、中石科技、歌尔股份等，分 别上涨1.03%、0.46%、0.14%。 今日涨跌幅居前的概念板块 | 概念 | 今日涨跌幅（%） | 概念 | 今日涨跌幅（%） | | --- | --- | --- | --- | | 中韩自贸区 | 4.23 | 特钢概念 | -0.93 | | 细胞免疫治疗 | 3.87 | 医疗废物处理 | -0.51 | | 重组蛋白 | 3.64 | 同花顺果指数 | -0.41 | | 足球概念 | 3.56 | 无线充电 | -0.39 | | 毛发医疗 | 3.51 | 光热发电 | -0.33 | | CRO概念 | 3.41 | 深圳国企改革 | -0.24 | | 创新药 | 3.38 | F5G概念 | -0.23 | | 培育钻石 | 3.11 | 租售同权 | -0.22 | | 仿制药一致性评价 | 3.08 | 一体化压铸 | -0.21 | | 眼科医疗 | 3.08 | 硅能源 | -0.18 ...

广东领益智造股份有限公司 关于回购公司股份的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、股份回购方案概述 广东领益智造股份有限公司（以下简称"公司"）于 2025 年 4 月 11 日召开第 六届董事会第十一次会议，审议通过了《关于回购公司股份方案的议案》，同意 公司以自有资金及回购专项贷款回购部分公司股份；回购股份的种类为公司已发 行上市的人民币普通股（A 股）股票，回购股份的资金总额不低于人民币 2 亿元 （含），不超过人民币 4 亿元（含），回购股份的价格不超过人民币 13.18 元/股 （含本数）。公司已在中国证券登记结算有限责任公司深圳分公司开立了回购专 用证券账户，并分别于 2025 年 4 月 15 日及 2025 年 4 月 19 日披露了《关于回购 公司股 份 方 案 的 公 告 》《 回 购 报 告 书 》， 具 体 内 容 详 见 巨 潮 资 讯 网 （www.cninfo.com.cn）和公司指定信息披露报刊的相关公告。 公司分别于 2025 年 3 月 27 日、2025 年 4 月 22 日召开第六届董事会第十次 ...

广东领益智造股份有限公司 可转换公司债券受托管理事务报告 | 证券代码：002600 | 证券简称：领益智造 | | --- | --- | | 债券代码：127107 | 债券简称：领益转债 | 广东领益智造股份有限公司 向不特定对象发行可转换公司债券 受托管理事务报告 （2024年度） 债券受托管理人 二〇二五年五月 1 广东领益智造股份有限公司 可转换公司债券受托管理事务报告 重要声明 本报告依据《公司债券发行与交易管理办法》（以下简称"《管理办法》"） 《关于广东领益智造股份有限公司向不特定对象发行可转换公司债券之债券受 托管理协议》（以下简称"《受托管理协议》"）《广东领益智造股份有限公司向 不特定对象发行可转换公司债券募集说明书》（以下简称"《募集说明书》"） 《广东领益智造股份有限公司 2024 年年度报告》等相关公开信息披露文件、第 三方中介机构出具的专业意见等，由本次债券受托管理人国泰海通证券股份有 限公司（以下简称"国泰海通"）编制。国泰海通对本报告中所包含的从上述文 件中引述内容和信息未进行独立验证，也不就该等引述内容和信息的真实性、 准确性和完整性做出任何保证或承担任何责任。 本报告不 ...